Free Trial

Shaftesbury Capital (SHC) Competitors

Shaftesbury Capital logo
GBX 132.50 -0.60 (-0.45%)
As of 08:05 AM Eastern

SHC vs. TALK, AMS, SSY, FME, and AGL

Should you buy Shaftesbury Capital stock or one of its competitors? MarketBeat compares Shaftesbury Capital with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Shaftesbury Capital include TalkTalk Telecom Group (TALK), Advanced Medical Solutions Group (AMS), Scisys Group (SSY), Future Metals (FME), and ANGLE (AGL). These companies are all part of the "healthcare" industry.

How does Shaftesbury Capital compare to TalkTalk Telecom Group?

TalkTalk Telecom Group (LON:TALK) and Shaftesbury Capital (LON:SHC) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

Shaftesbury Capital has a consensus price target of GBX 182.80, indicating a potential upside of 37.96%. Given Shaftesbury Capital's stronger consensus rating and higher possible upside, analysts plainly believe Shaftesbury Capital is more favorable than TalkTalk Telecom Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TalkTalk Telecom Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Shaftesbury Capital has lower revenue, but higher earnings than TalkTalk Telecom Group. TalkTalk Telecom Group is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TalkTalk Telecom Group£1.52B0.00N/A£12.80N/A
Shaftesbury Capital£238.90M10.11£39.54M£18.507.16

37.8% of Shaftesbury Capital shares are held by institutional investors. 0.5% of Shaftesbury Capital shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

TalkTalk Telecom Group pays an annual dividend of GBX 0.03 per share. Shaftesbury Capital pays an annual dividend of GBX 3.70 per share and has a dividend yield of 2.8%. TalkTalk Telecom Group pays out 0.2% of its earnings in the form of a dividend. Shaftesbury Capital pays out 20.0% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Shaftesbury Capital has a net margin of 141.28% compared to TalkTalk Telecom Group's net margin of 0.00%. Shaftesbury Capital's return on equity of 8.78% beat TalkTalk Telecom Group's return on equity.

Company Net Margins Return on Equity Return on Assets
TalkTalk Telecom GroupN/A N/A N/A
Shaftesbury Capital 141.28%8.78%1.52%

In the previous week, TalkTalk Telecom Group's average media sentiment score of 0.00 equaled Shaftesbury Capital'saverage media sentiment score.

Company Overall Sentiment
TalkTalk Telecom Group Neutral
Shaftesbury Capital Neutral

Summary

Shaftesbury Capital beats TalkTalk Telecom Group on 10 of the 13 factors compared between the two stocks.

How does Shaftesbury Capital compare to Advanced Medical Solutions Group?

Shaftesbury Capital (LON:SHC) and Advanced Medical Solutions Group (LON:AMS) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, dividends, risk, profitability, institutional ownership, earnings, analyst recommendations and valuation.

Shaftesbury Capital has a net margin of 141.28% compared to Advanced Medical Solutions Group's net margin of 4.35%. Shaftesbury Capital's return on equity of 8.78% beat Advanced Medical Solutions Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Shaftesbury Capital141.28% 8.78% 1.52%
Advanced Medical Solutions Group 4.35%3.87%2.35%

In the previous week, Advanced Medical Solutions Group had 2 more articles in the media than Shaftesbury Capital. MarketBeat recorded 2 mentions for Advanced Medical Solutions Group and 0 mentions for Shaftesbury Capital. Advanced Medical Solutions Group's average media sentiment score of 0.91 beat Shaftesbury Capital's score of 0.00 indicating that Advanced Medical Solutions Group is being referred to more favorably in the news media.

Company Overall Sentiment
Shaftesbury Capital Neutral
Advanced Medical Solutions Group Positive

Shaftesbury Capital has higher revenue and earnings than Advanced Medical Solutions Group. Shaftesbury Capital is trading at a lower price-to-earnings ratio than Advanced Medical Solutions Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shaftesbury Capital£238.90M10.11£39.54M£18.507.16
Advanced Medical Solutions Group£228.94M2.05£11.22M£4.5247.79

37.8% of Shaftesbury Capital shares are held by institutional investors. Comparatively, 22.6% of Advanced Medical Solutions Group shares are held by institutional investors. 0.5% of Shaftesbury Capital shares are held by company insiders. Comparatively, 4.1% of Advanced Medical Solutions Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Shaftesbury Capital currently has a consensus target price of GBX 182.80, indicating a potential upside of 37.96%. Advanced Medical Solutions Group has a consensus target price of GBX 270.25, indicating a potential upside of 25.12%. Given Shaftesbury Capital's stronger consensus rating and higher possible upside, analysts plainly believe Shaftesbury Capital is more favorable than Advanced Medical Solutions Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Advanced Medical Solutions Group
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

Shaftesbury Capital has a beta of 0.953, suggesting that its stock price is 5% less volatile than the broader market. Comparatively, Advanced Medical Solutions Group has a beta of 0.718, suggesting that its stock price is 28% less volatile than the broader market.

Shaftesbury Capital pays an annual dividend of GBX 3.70 per share and has a dividend yield of 2.8%. Advanced Medical Solutions Group pays an annual dividend of GBX 2.68 per share and has a dividend yield of 1.2%. Shaftesbury Capital pays out 20.0% of its earnings in the form of a dividend. Advanced Medical Solutions Group pays out 59.3% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Shaftesbury Capital is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Shaftesbury Capital beats Advanced Medical Solutions Group on 13 of the 18 factors compared between the two stocks.

How does Shaftesbury Capital compare to Scisys Group?

Shaftesbury Capital (LON:SHC) and Scisys Group (LON:SSY) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, profitability, institutional ownership, media sentiment, earnings, dividends and analyst recommendations.

37.8% of Shaftesbury Capital shares are owned by institutional investors. 0.5% of Shaftesbury Capital shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Shaftesbury Capital presently has a consensus price target of GBX 182.80, indicating a potential upside of 37.96%. Given Shaftesbury Capital's stronger consensus rating and higher probable upside, equities analysts clearly believe Shaftesbury Capital is more favorable than Scisys Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Scisys Group
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, Shaftesbury Capital's average media sentiment score of 0.00 equaled Scisys Group'saverage media sentiment score.

Company Overall Sentiment
Shaftesbury Capital Neutral
Scisys Group Neutral

Shaftesbury Capital has a net margin of 141.28% compared to Scisys Group's net margin of 0.00%. Shaftesbury Capital's return on equity of 8.78% beat Scisys Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Shaftesbury Capital141.28% 8.78% 1.52%
Scisys Group N/A N/A N/A

Shaftesbury Capital has higher revenue and earnings than Scisys Group. Scisys Group is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shaftesbury Capital£238.90M10.11£39.54M£18.507.16
Scisys Group£59.06M0.00N/A£1.40N/A

Shaftesbury Capital pays an annual dividend of GBX 3.70 per share and has a dividend yield of 2.8%. Scisys Group pays an annual dividend of GBX 0.02 per share. Shaftesbury Capital pays out 20.0% of its earnings in the form of a dividend. Scisys Group pays out 1.4% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Summary

Shaftesbury Capital beats Scisys Group on 11 of the 13 factors compared between the two stocks.

How does Shaftesbury Capital compare to Future Metals?

Future Metals (LON:FME) and Shaftesbury Capital (LON:SHC) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, analyst recommendations, media sentiment, risk, earnings and profitability.

37.8% of Shaftesbury Capital shares are owned by institutional investors. 0.1% of Future Metals shares are owned by insiders. Comparatively, 0.5% of Shaftesbury Capital shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Shaftesbury Capital has higher revenue and earnings than Future Metals. Future Metals is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Future Metals£155.84K67.65-£7.83M-£0.40N/A
Shaftesbury Capital£238.90M10.11£39.54M£18.507.16

Shaftesbury Capital has a consensus target price of GBX 182.80, suggesting a potential upside of 37.96%. Given Shaftesbury Capital's stronger consensus rating and higher probable upside, analysts clearly believe Shaftesbury Capital is more favorable than Future Metals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Future Metals
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Future Metals has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, Shaftesbury Capital has a beta of 0.953, meaning that its stock price is 5% less volatile than the broader market.

In the previous week, Future Metals had 1 more articles in the media than Shaftesbury Capital. MarketBeat recorded 1 mentions for Future Metals and 0 mentions for Shaftesbury Capital. Future Metals' average media sentiment score of 0.75 beat Shaftesbury Capital's score of 0.00 indicating that Future Metals is being referred to more favorably in the media.

Company Overall Sentiment
Future Metals Positive
Shaftesbury Capital Neutral

Shaftesbury Capital has a net margin of 141.28% compared to Future Metals' net margin of -1,051.73%. Shaftesbury Capital's return on equity of 8.78% beat Future Metals' return on equity.

Company Net Margins Return on Equity Return on Assets
Future Metals-1,051.73% -11.89% -11.36%
Shaftesbury Capital 141.28%8.78%1.52%

Summary

Shaftesbury Capital beats Future Metals on 12 of the 16 factors compared between the two stocks.

How does Shaftesbury Capital compare to ANGLE?

ANGLE (LON:AGL) and Shaftesbury Capital (LON:SHC) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, media sentiment, earnings and analyst recommendations.

Shaftesbury Capital has higher revenue and earnings than ANGLE. ANGLE is trading at a lower price-to-earnings ratio than Shaftesbury Capital, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ANGLE£2.62M2.89-£21.76M-£4.80N/A
Shaftesbury Capital£238.90M10.11£39.54M£18.507.16

Shaftesbury Capital has a consensus target price of GBX 182.80, indicating a potential upside of 37.96%. Given Shaftesbury Capital's stronger consensus rating and higher probable upside, analysts clearly believe Shaftesbury Capital is more favorable than ANGLE.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ANGLE
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Shaftesbury Capital
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

ANGLE has a beta of 0.22, meaning that its share price is 78% less volatile than the broader market. Comparatively, Shaftesbury Capital has a beta of 0.953, meaning that its share price is 5% less volatile than the broader market.

17.5% of ANGLE shares are held by institutional investors. Comparatively, 37.8% of Shaftesbury Capital shares are held by institutional investors. 2.7% of ANGLE shares are held by insiders. Comparatively, 0.5% of Shaftesbury Capital shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, ANGLE had 1 more articles in the media than Shaftesbury Capital. MarketBeat recorded 1 mentions for ANGLE and 0 mentions for Shaftesbury Capital. ANGLE's average media sentiment score of 0.20 beat Shaftesbury Capital's score of 0.00 indicating that ANGLE is being referred to more favorably in the media.

Company Overall Sentiment
ANGLE Neutral
Shaftesbury Capital Neutral

Shaftesbury Capital has a net margin of 141.28% compared to ANGLE's net margin of -732.40%. Shaftesbury Capital's return on equity of 8.78% beat ANGLE's return on equity.

Company Net Margins Return on Equity Return on Assets
ANGLE-732.40% -89.82% -29.89%
Shaftesbury Capital 141.28%8.78%1.52%

Summary

Shaftesbury Capital beats ANGLE on 13 of the 16 factors compared between the two stocks.

Get Shaftesbury Capital News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHC vs. The Competition

MetricShaftesbury CapitalREIT IndustryReal Estate SectorLON Exchange
Market Cap£2.42B£3.26B£2.02B£2.79B
Dividend Yield2.95%5.68%7.16%6.13%
P/E Ratio7.165.1829.31364.83
Price / Sales10.11298.08808.0287,614.39
Price / CashN/A113.0568.0327.85
Price / Book0.692.481.327.83
Net Income£39.54M£89.50M-£124.57M£5.88B
7 Day Performance-2.07%1.18%-0.49%6.72%
1 Month Performance-0.01%1.12%-1.37%9.93%
1 Year Performance-8.01%16.75%1.11%75.98%

Shaftesbury Capital Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHC
Shaftesbury Capital
N/AGBX 132.50
-0.5%
GBX 182.80
+38.0%
-7.0%£2.42B£238.90M7.163,000
TALK
TalkTalk Telecom Group
N/AN/AN/AN/A£1.11B£1.52B7.57500
AMS
Advanced Medical Solutions Group
3.1047 of 5 stars
GBX 220
+0.5%
GBX 270.25
+22.8%
+4.1%£477.21M£228.94M48.6710
SSY
Scisys Group
N/AN/AN/AN/A£75.14M£59.06M180.711,376
FME
Future Metals
N/AGBX 1.10
-2.2%
N/A+104.1%£10.54M£155.84KN/A123,200

Related Companies and Tools


This page (LON:SHC) was last updated on 6/3/2026 by MarketBeat.com Staff.
From Our Partners